We chose these two CFHR5 variations because these were the most abundant CFHR5 alterations identified in our patients suffering from IC-MPGN or C3G (and atypical hemolytic uremic syndrome). This evidence concerns the gene CFHR5 and primary membranoproliferative glomerulonephritis.